Know who answers what
Follow a MOTS-C offer through its separate commercial, clinical and pharmacy questions, with a clear record of the information the campaign provides and the details still needing confirmation.
Explore the detailsA closer look
A MOTS-C campaign can introduce a product, but different parts of a possible order need different answers. Order Console organizes questions by responsibility: the provider’s billing terms, the clinician’s assessment and the pharmacy’s dispensing information. That makes it easier to request a specific clarification without assuming a single advertisement explains the entire process.
CoreAge Rx is the promoted provider here. On November 7, 2026, its MOTS-C campaign was active while the general product page displayed Coming soon. Neither intake nor fulfillment has been tested. Current access requires confirmation, and a clinical assessment must address suitability and the evidence limitations of the proposed preparation.
Take this with you
Who can confirm whether MOTS-C enrollment is currently available in my state?
Which clinician would assess whether this preparation fits my medical needs?
Which pharmacy would dispense a prescribed preparation and answer label questions?
Who can explain the billed-now amount, renewal schedule and cancellation conditions?
Sponsored · CoreAge Rx
Prices below are advertised by CoreAge Rx. Confirm eligibility, current terms, and total charges with the provider before enrolling.
Advertised Black Friday terms
$597 billed upfront for six months
Advertised through November 27, 2026, at 11:59 p.m. Eastern. Confirm current checkout, cancellation and renewal terms.
Compounded and not FDA-approved. Human evidence is limited; discuss risks and suitability with a licensed clinician.
Provider sourcePromotional placement. This publication is part of a commonly owned promotional network supporting CoreAge Rx. Placement is not an independent ranking or a claim that treatment is appropriate for you. How this site works.
The reading room
Organize your MOTS-C questions around commercial terms, clinical assessment and dispensing details so that each unresolved point reaches an appropriate source of clarification.
Create a concise record that preserves the source, status and unresolved questions attached to a MOTS-C offer without treating advertising as a completed order.
Before you decide
No. The source check established what CoreAge Rx’s public campaign and product pages said, not a completed care pathway or a specific dispensing arrangement. Ask the provider to identify the clinician and pharmacy involved in any proposed treatment.
A clear payment answer does not establish medical suitability, and a clinical discussion does not explain every billing condition. Keep both sets of questions. The provider should clarify commercial terms while the treating clinician addresses the proposed preparation and your circumstances.
CoreAge Rx lists $597 upfront for a six-month MOTS-C plan, equivalent to $99.50 per month. The equivalent is not evidence of monthly billing. Confirm the actual order total, included services and renewal conditions with the provider.
FDA states it has not identified human exposure data for drug products containing MOTs-C and describes potential immunogenicity and peptide-impurity concerns. Ask how those limitations affect the proposed preparation and your decision; marketing language cannot resolve them.